Kura Oncology reports positive long-term cancer drug trial data Jun 11, 2026 08:03AM
Kura Oncology (KURA) and Kyowa Kirin Report Positive Updated Combination Data for Ziftomenib in Newly Diagnosed AML at 2025 European Hematology Association Congress Jun 12, 2025 07:31AM
Kura Oncology (KURA) and Kyowa Kirin Announce FDA Acceptance and Priority Review of New Drug Application for Ziftomenib Jun 1, 2025 07:14PM
Kura Oncology (KURA) and Kyowa Kirin announce abstract on ziftomenib trial May 22, 2025 05:36PM
Kura Oncology (KURA) and Kyowa Kirin Announce Submission of New Drug Application for Ziftomenib to FDA Apr 8, 2025 07:30AM


Dec 9, 2024 07:05AM Kura Oncology (KURA) and Kyowa Kirin Report Positive Combination Data for Ziftomenib at American Society of Hematology Annual Meeting